Madeleine Dean

Supporting Every at-Risk Veteran In Critical Emergencies Act of 2025 or the SERVICE Act of 2025

This bill authorizes the Office of Community Oriented Policing Services within the Department of Justice to make grants to support the creation and operation of veterans' response teams in state, local, and tribal law enforcement agencies.

Health Care Affordability Act of 2025

This bill makes permanent temporary changes enacted by the American Rescue Plan Act of 2021 (ARPA) and the Inflation Reduction Act of 2022 (IRA) that generally expand eligibility for and increase the amount of the premium tax credit.

Currently, eligible taxpayers may be able to claim the premium tax credit, which applies toward the cost of obtaining health insurance through health insurance exchanges. To be eligible for the premium tax credit, a taxpayer’s household income must meet or exceed 100% of the federal poverty level (FPL) and, after 2025, may not exceed 400% of the FPL (maximum income limit). For 2021-2025, the ARPA and IRA eliminated the maximum income limit, which generally expands eligibility for the premium tax credit.

Further, under current law, the amount of the premium tax credit is (1) generally the plan premium (conditions apply), minus (2) the taxpayer’s household income multiplied by the applicable percentage. The applicable percentage is a specific percentage that varies depending on which of six income ranges (adjusted for inflation after 2025) the taxpayer’s household income falls within. For 2021-2025, the ARPA and IRA lowered the applicable percentages and eliminated the adjustment of the applicable percentages for inflation, which generally increases the amount of the premium tax credit.

The bill makes permanent the elimination of the 400% maximum income limit, the lower applicable percentages, and the elimination of the inflation adjustment for the applicable percentages.

Spotted Lanternfly Research and Development Act

This bill includes combatting the spotted lanternfly (Lycorma delicatula) as a Department of Agriculture (USDA) high-priority research and extension area and reauthorizes other USDA research and extension initiatives.

The bill specifically allows grants for developing and disseminating research-based tools and treatments to combat the spotted lanternfly, which is an invasive species native to Asia that feeds on a wide range of crops and plants (e.g., grapes, apples, hops, walnuts, and hardwood trees).

Further, the bill reauthorizes USDA grants to support competitive specialized research and extension activities, including high-priority areas, through FY2030. The bill also specifically reauthorizes through FY2030

• the Pulse Crop Health Initiative;

• the Comprehensive Food Safety Training Network;

• pollinator protection research and extension grants;

• increased USDA capacity and infrastructure to address and conduct research on colony collapse disorder and other pollinator issues; and

• a USDA-conducted nationwide honey bee pest, pathogen, health, and population status surveillance program.

Give Kids a Chance Act of 2025

This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.

Specifically, the bill

• modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met;

• permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement;

• renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and

• reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.

The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra, a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

This resolution expresses support for the designation of Journeyman Lineworkers Recognition Day. (A journeyman lineworker is a person who builds and maintains electrical power systems.)

AUKUS Reform for Military Optimization and Review Act or the ARMOR Act

This bill expedites review processes for the export of certain defense articles and services to Australia, the United Kingdom (UK), and Canada.

Specifically, the bill exempts from certain congressional notification requirements the export or transfer of defense articles or services subject to the defense trade partnership between Australia, the UK, and the United States (AUKUS). (Under current law, exports and transfers of defense articles and services to Australia and the UK are exempt from certain export controls pursuant to AUKUS. Separately, approvals of certain commercial agreements and the export of certain defense articles, services, and equipment are generally subject to congressional notification requirements and a waiting period.) Under the bill, exports and transfers that are exempt from export controls pursuant to AUKUS are also exempt from these congressional notification requirements.

Further, the bill requires the Department of State to periodically review the list of defense articles and services excluded from AUKUS to ensure it includes only items that (1) are required by statute to be included, or (2) require licensing review for national security reasons.

Finally, the bill explicitly states that the existing expedited review process for applications to export certain commercial, advanced-technology defense articles and services to Australia, the UK, and Canada is available to all exports and transfers, including reexports, retransfers, temporary imports, and brokering activity. Such exports and transfers must take place wholly within or between the territory of these countries or the United States.